To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/879 - attachment 2 (PDF)

Found: Eye discharge 11 0 Eye inflammation 2 0 Eye irritation 2 0 Eye pruritus 6 0

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/937 - attachment 2 (PDF)

Found: Eye discharge 11 0 Eye inflammation 2 0 Eye irritation 2 0 Eye pruritus 6 0

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1107) - attachment 2 (PDF)

Found: infections, inflammations and associated manifestations Eye irritation 1 0 Eye pruritus

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 3 (PDF)

Found: disorders NEC Dark circles under eyes 4 0 Eye disorder 6 0 Eye pain 24 0 Eye

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1107) - attachment 7 (PDF)

Found: 1 0 Eye oedema 1 0 Eye swelling 12 0 Ocular infections, inflammations and associated

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/996) - attachment 1 (PDF)

Found: Eye haemorrhage 1 0 Ocular disorders NEC Eye oedema 1 0 Eye swelling 1 0 Periorbital

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 9 (PDF)

Found: Eye haemorrhage 1 0 Ocular disorders NEC Eye oedema 1 0 Eye swelling 1 0 Periorbital

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 28 November 2022
Document: Freedom of Information request (FOI 22/1093) - attachment 2 (PDF)

Found: Eye disorder 10 0 Eye pain 27 0 Eye swelling 11 0 Eyelid pain 1 0 Eyelids

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 8 (PDF)

Found: , inflammations and associated manifestations Eye pruritus 1 0 Ocular hyperaemia 1 0

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Jan. 17 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022
Document: Freedom of Information request (FOI 22/981) - attachment 7 (PDF)

Found: Eye discharge 9 0 Eye inflammation 2 0 Eye irritation 2 0 Eye pruritus 6 0